Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: HEALTH

New Technology Can Now Test for Airborne COVID and Several Strains of the Common Flu


NORTH CHICAGO, Ill., March 01, 2023 (GLOBE NEWSWIRE) -- AirAnswers, the leader in air sampling and testing technology, is expanding their test offering to include a panel of airborne viruses comprising COVID-19, Flu A, Flu B, and RSV (Respiratory Syncytial Virus). RSV is one of the most common causes of childhood illness and can affect adults. These constitute a "tripledemic" panel of viruses that can easily be transmitted in the air. The flexibility of the patented technology allows AirAnswers to expand their current comprehensive test menu for airborne molds, allergens, , and mycotoxins all of which can cause significant health problems for people living and working indoors.

"The COVID pandemic and the emergence of RSV has emphasized the importance of indoor air quality in the overall maintenance of a healthy environment," says Jim Koziarz, CEO. "AirAnswers is the only product that brings state of the art laboratory testing to the air we breathe. Our product provides a comprehensive analysis of the air which can be used to develop a successful and cost-effective remediation program. Periodic testing with AirAnswers certifies the remediation results and helps to monitor the facility to maintain a healthy environment. Since the product is screening for these airborne pathogens, a negative result certifies that the air is clean."

The AirAnswers technology can capture airborne particles as small as 0.1 micron. Particles this size do not settle out of the air and are small enough to deeply penetrate the human pulmonary system.

The AirAnswers state-of-the art collection system is about the size of a gallon package of milk and works silently to collect a massive amount of air equal to 55,000 gallons of air in a single day.

AirAnswers also provides the user the ability to collect and identify any new emerging airborne threats like new variants of COVID-19. The system acts as a sentry to warn of harmful levels of airborne pathogens before they become a major issue.

AirAnswers is actively looking to identify partners who can use the data to design and implement effect remediation and maintenance strategies.

To learn more, contact: Katie Gragg, Marketing Manager at AirAnswers® 866-539-4253, [email protected]

About AirAnswers, Inc:

Based in North Chicago, Illinois, AirAnswers® is the only company providing specific airborne biological contaminant detection for indoor air quality companies and experts. AirAnswers' highly sensitive patented technology collects and measures biological agents in the air, including molds, mycotoxins, allergens, and viruses down to the 0.1 microns in size. Developed in collaboration with institutions including Johns Hopkins University, The University of Chicago, Harvard University, and Argonne National Laboratory, the AirAnswers mission is to deliver customized prevention and management solutions to improve health and peace of mind by transforming indoor environments everywhere. AirAnswers has been validated with an extensive portfolio of patents* and publications in peer-reviewed literature. www.airanswers.com



These press releases may also interest you

at 18:42
Housecall Providers, a nonprofit home-based medical organization invites the community to Sellwood Park, Saturday, June 1, from noon ? 4:00 p.m. for an inspiring afternoon of learning, connection and some friendly competition. Toss...

at 18:30
BioSyent Inc. ("BioSyent", TSX Venture: RX) released today its financial results for the three months (Q1) ended March 31, 2024. Key highlights include:  (CAD)Q1 2024% Change vs.Q1 2023Trailing Twelve Months(TTM) March 31, 2024% Change vs.TTMMarch...

at 18:30
IntraCare, a prominent Texas-based MSO, recently signed a partnership agreement with one of Arizona's largest and leading healthcare providers, Cornerstone Family Medicine, which operates...

at 18:30
Heroes Boost LLC, a new company committed to transforming the health and wellness space, proudly announces the launch of its flagship product, Smart Shrooms. Recognizing the powerful benefits of mushrooms, Heroes Boost aims to bring these...

at 18:00
BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.045 per common share, payable in Canadian Dollars on June 15, 2024, to shareholders of record at the...

at 18:00
This insightful session is scheduled for May 21, 2024, at 2 pm ET and is co-sponsored by e4health and CBIZ KA Consulting Services. The webinar will feature an in-depth discussion led by Panacea's executive leadership team. They will delve into the...



News published on and distributed by: